Sanger Science

We caught up with experts from the Cellular Services team at the Wellcome Sanger Institute to learn more about what organoids are and how we are using them in our research.

Genomic research is lacking representative data, which limits our ability to understand diseases and develop treatments. To fix this, we need to prioritise local leadership, capacity building, and equitable partnerships. Dr Gosia Trynka, Group Leader at the Wellcome Sanger Institute, shares her experience with Project JAGUAR, a large-scale Latin American genomics collaboration that aims to make genomics data more representative and support fair science and healthcare.

Representation in research is key to ensure that science can benefit all of us. The Wellcome Sanger Institute is one of the first research institutions in the UK to launch an organisational Representative Research Strategy. In this blog, we reflect on the Strategy, what it sets out to achieve, what it means and why it is important in today’s society.

It has been 25 years since the announcement of the Human Genome Project. We take a look back at the history of the project with some of our long servers at the Sanger Institute, including what it has allowed us to achieve and where it may lead to in the future.

Curious about the nasal microbiome? Staff Scientist Katie Bellis shares her passion for infectious disease research and personal insights into life at the Wellcome Sanger Institute.

With the World Health Organization (WHO) recently adopting an agreement on pandemic preparedness, we spoke with John Sillitoe, Director of the Sanger Institute’s Genomic Surveillance Unit, to find out more about the role data and genomics can play in preventing future outbreaks.